摘要
目的探讨分析罗格列酮联合二甲双胍治疗2型糖尿病的临床效果。方法选取我院治疗的80例2型糖尿病患者,随机分两组,在饮食和运动等常规糖尿病治疗基础上,对照组予以二甲双胍治疗,观察组再予以罗格列酮治疗,比较两组治疗后的效果情况。结果两组治疗后FPG、2hPG、HbA1c和BMI出现显著性差异;对照组的显效率和总有效率均显著低于观察组;对照组治疗2个月后5例不良反应,观察组仅出现3例,无显著性差异例。结论罗格列酮联合二甲双胍治疗2型糖尿病临床效果显著,不良反应低,具有协同作用。
Objective To explore and analyze the clinical effect of rosiglitazone combined with melbine on treating type 2 diabetes mellitus.Methods 80 patients with type 2 diabetes mellitus treated in our hospital were selected and divided into 2 groups randomly.On the basis of routine diabetes treatment including diet and exercise,the control group were treated with melbine,and the observation group were given rosiglitazone combined with melbine.Comparing the treatment effect of 2 groups.Result After treatment,there was evident difference in FPG,2hPG,HbA1c and BMI between 2 groups.The evident efficiency and the total effective rate of the control group were lower apparently than that of the observation group.The control group had 5 patients with adverse reactions 2 months after treatment,and there were only 3 cases in the observation group,which had no evident significance.Conclusions Rosig litazone combined with melbine to treat type 2 diabetes mellitus has evident clinical effect and low adverse reactions,and has synergistic action.
出处
《中国医药指南》
2013年第9期56-57,共2页
Guide of China Medicine
关键词
内镜
医院感染
危险因素
对策
Endoscopic
Nosocomial infection
Risk factors
Countermeasures
